Drug Shortage Report for ALTACE HCT
| Report ID | 11351 |
| Drug Identification Number | 02283174 |
| Brand name | ALTACE HCT |
| Common or Proper name | ALTACE HCT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE RAMIPRIL |
| Strength(s) | 25.0MG 5.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | NA |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-05-26 |
| Estimated end date | 2017-07-15 |
| Actual end date | 2017-09-01 |
| Shortage status | Resolved |
| Updated date | 2017-09-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-09-02 | English | Compare |
| v5 | 2017-09-01 | French | Compare |
| v4 | 2017-09-01 | English | Compare |
| v3 | 2017-05-27 | English | Compare |
| v2 | 2017-05-26 | French | Compare |
| v1 | 2017-05-26 | English | Compare |
Showing 1 to 6 of 6